SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DECODE GENETICS-*DCGN
An SI Board Since July 2000
Posts SubjectMarks Bans Symbol
313 31 0 DCGN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
163Good CC this morning, IMHO. There is a lot to like with DCGN, but I’m not yet coDewDiligence_on_SI-3/4/2005
162deCODE genetics Announces Full-year 2004 Financial Results Thursday March 3, 4:1nigel bates-3/4/2005
161Family Privacy and Death — Antigone, War, and Medical Research George J. Annas,zeta1961-2/5/2005
160deCODE Submits IND for Novel Anti-atherosclerosis Compound DG041 REYKJAVIK, Icenigel bates-1/13/2005
159deCODE to Conduct Phase II Clinical Trial in Asthma Friday December 17, 6:59 am nigel bates-12/17/2004
158You got filled in the Low 3's? Who's your broker?keokalani'nui-11/25/2004
157DCGN is a strong buy in here, as this joint venture is further validation by RocBiotech Jim-11/23/2004
156Roche and deCODE Announce Collaboration to Co-Develop PDE4 Inhibitors for Vasculnigel bates-11/23/2004
155Typo - MPO (myeloperoxidase). ApologiesClarksterh-11/7/2004
154PMO?tom pope-11/7/2004
153Some questions for the board about DeCode's heart disease inflammation blockClarksterh-11/7/2004
152Piper: DCGN :Follow up from DG031 Results Conference Call October 19, 2004 *mopgcw-10/27/2004
151Piper :DCGN :DG031 Phase IIa Data Looks Good October 19, 2004 Edward A. Tmopgcw-10/27/2004
150deCODE Announces Positive Results from Phase IIa Clinical Trial of DG031 Tuesdaynigel bates-10/19/2004
149deCODE Awarded $24 Million by NIH to Study Genetics of Infectious Disease and Vanigel bates-10/8/2004
148Roche says commitment to Decode is long-term BASEL, Switzerland, Sept 13 (Reutenigel bates-9/13/2004
147deCODE genetics Announces Appointment of Deloitte & Touche as Independent Acnigel bates-9/10/2004
146<i>my only hindsight wish is that I did not sell my $2 holdings in the $4-nigel bates-8/29/2004
145Tom- I like the technology that DCGN has, and my only hindsight wish is that Biotech Jim-8/29/2004
144Yes, I suspect there's more there than Piper Jaffray read into it, and the stom pope-8/29/2004
143Tom- Since the first statement in the 8K filing letter was "The current coBiotech Jim-8/29/2004
142Here's hoping. :-)nigel bates-8/27/2004
141Looks like you made a good buy, Nigel: <i>09:33 ET DCGN defended at Pipertom pope-8/27/2004
140Looks like it was as low as 4.98, around 5.37 now.tom pope-8/27/2004
139Bought a few in Europe just now, and may add a few more if the US market opens mnigel bates-8/27/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News